Contact

An iPSC-dedicated GMP facility built for consistent, scalable manufacturing.

Our 32,000+ sq. ft. headquarters in Mont-Saint-Guibert is the first facility designed exclusively for iPSC-derived cell therapy production. We provide a controlled, certified GMP environment where iPSC development and manufacturing follow defined, reproducible workflows.

Cellistic Facility

Full-service. One location. Streamlined for your success.

Equipped for cell therapy and regenerative medicine excellence.

Manufacturing cell therapies for clinical use requires predictable, tightly controlled manufacturing conditions. Cellistic’s facility was built for that purpose from the outset. 

All materials and operations are validated according with cGMP standards, and manufacturing is conducted in an EMA-certified, FDA/PMDA-compliant GMP environment. With more than 400 total batches released and a record of completed GMP and GTP inspections, the site offers the operational discipline, scientific rigour and a full support team all under one roof. 

Echo-NK

Echo™-NK

Echo-Cardio

Echo™-Cardio

Echo-Endothelial

Echo™-Endothelial

Echo T-Cell

Echo™-T

A manufacturing environment designed
for flexibility and scale.

Our facility’s layout, environmental controls, and validated workflows (including dedicated clean rooms for cell line development and GMP manufacturing) support consistent performance across iPSC-derived programs. Core capabilities include:

5Grade B Manufacturing Suites

4Grade C
Manufacturing Suites

100+Maximum capacity (in liters)

 

7GMP Inspections completed

 

5GTP inspections
completed

 

100+Batches 
released

 

Artboard 1 1

See how our GMP facility can advance your manufacturing needs.

Connect with our team to review feasibility, timelines, and how we can work together to move your cell therapy programs forward.

Artboard 1 1

Purpose-built to deliver on iPSC potential.

Our headquarters in Mont-Saint-Guibert, Belgium, is home to the world’s first facility designed exclusively for iPSC-derived cell therapy production, built from the start to lay the foundation for what is today an EMA-certified, FDA-compliant GMP environment.

Systems that support controlled, scalable manufacturing.

Our facility’s closed, automated systems support controlled, consistent workflows from run to run, maintaining a stable environment and reducing the risk of contamination during processing. For scale-up, we rely on stirred-tank bioreactors that support suspension culture and controlled expansion, with capacity up to 50 liters / 75 billion cells. This gives developers the flexibility to advance programs from early work into clinical-scale production.

Cellistic Facility Indoor
Cellistic Tech Transfer

A modular architecture ready for emerging iPSC applications.

The Mont-Saint-Guibert facility’s modular structure allows Cellistic to support additional iPSC-derived applications as development needs expand, so we can integrate new workflows while maintaining validated GMP processes.

Cellistic Building

Begin your manufacturing discussion with the Cellistic team.

Get a deeper look at the facility and learn how our dedicated GMP environment can support your program’s next steps.